Status:
COMPLETED
ALPHA Sitagliptin Add on to Metformin (0431-103)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Canadian physicians to experience in real life clinical practice the efficacy and tolerability of adding sitagliptin to their patients who have their glycemic levels inadequately controlled while on m...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient Is Currently On Monotherapy With Metformin For At Least 10 Weeks Prior To Study Entry
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2009
Estimated Enrollment :
608 Patients enrolled
Trial Details
Trial ID
NCT00833027
Start Date
March 1 2008
End Date
October 30 2009
Last Update
May 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.